CA19-9 to monitor pancreatic cancer
Using CA19-9 to Better Understand Treatment Response in Pancreatic Cancer Pancreatic cancer is one of the most challenging cancers to treat. It is often diagnosed late, treatment options are limited, and patients and physicians alike must make important decisions based on incomplete or delayed information. ElmediX has developed an innovative medical device, the TempoCure®, to […]
The Human Body-Mimicking Phantom
Revolutionizing Cancer Treatment: The Human Body-Mimicking Phantom In the ever-evolving world of medical technology, researchers are constantly pushing the boundaries to improve cancer treatments. A recent breakthrough in this field comes in the form of a sophisticated human body-mimicking phantom, designed to test and validate convective hyperthermia devices. This innovative tool, developed by a team […]
Hyperthermia and Chemotherapy: Synergy for Tumor Treatment
The Synergistic Effects of HT and CT on Tumor Treatment The visual below illustrates the combined or synergistic effects of Hyperthermia Therapy (HT) and Chemotherapy (CT) on tumors. This comprehensive view is broken down into several subpanels, each providing a more detailed look at the pleiotropic effects of these therapies, which can be explored further […]
The complexity of pancreatic cancer
The complexity of pancreatic cancer Figure created with BioRender.com On this image, we see a depiction of a pancreatic tumor on the left and a detailed zoom-in of one of its cancer cells on the right. This panel illustrates the aggressive nature of pancreatic cancer, showing how it grows and invades without significant interference—highlighting why […]
Hyperthermia in combination with emerging targeted and immunotherapies
Hyperthermia in combination with emerging targeted and immunotherapies We’re proud to announce that our paper “Hyperthermia in Combination with Emerging Targeted and Immunotherapies” has been published open access in Cancers by MDPI. Despite significant advancements in the development of novel therapies, cancer continues to stand as a prominent global cause of death. In many cases, […]
ElmediX meets and greets France Digitale
ElmediX meets & greets France Digitale ElmediX was part of the Flemish delegation of startups at the meet & greet with France Digitale. The event was organised by Startup.Flanders, part of Flanders Investment & Trade (FIT). Flemish minister-president Jan Jambon was our host. During a pitch of several minutes, our CEOJohn-Paul Bogers proudly introduced ElmediX and […]
WBTT in advanced cancer-bearing dogs
WBTT in advanced cancer-bearing dogs Tolerability of long-term temperature controlled whole-body thermal treatment (WBTT) in advanced cancer-bearing dogs Thermal therapy is the application of external heat to the body to fight cancer cells. In contrast to local or regional thermal treatment, whole body thermal treatment (WBTT) raises the patient’s entire body temperature and is therefore […]
Long-term whole-body thermal treatment evaluated
Long-term whole-body thermal treatment evaluated Safety evaluation of long-term temperature controlled whole-body thermal treatment in female Aachen minipigs Whole-body thermal treatment (WBTT) increases the temperature of the entire body to a temperature of 41.5°C. A study conducted by ElmediX demonstrated that the application of WBTT in female Aachen minipigs for up to 8 hours was […]
Why is ElmediX developing biomarkers?
Why is ElmediX developing biomarkers? In a previous article on our website, we explained what biomarkers are and why they are useful in the fight against pancreatic cancer. In this article, we explain how biomarkers are developed. Early detection and diagnosis Pancreatic cancer still has a very low survival rate compared with other types of […]
What are biomarkers and why are they important?
What are biomarkers and why are they important? Despite major advances in available treatments for cancer in general, little progress has been made in pancreatic cancer in recent years. Survival rates remain very low compared to other types of cancer. A major reason for this is that symptoms only appear at a late stage of […]